Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Brainxell Inc Terminally differentiated human microglia ubiquitously expressing eGFP; Derived from iPSC line WC-30, male. No known neurological or psychiatric disorders. Contents: 1 vial of ≥2x10^6 viable cryopreserved cells
SDP

Supplier:  Brainxell Inc BX0901302M

Encompass_Preferred

Marker Expression: Confirmed expression of microglia surface markers including: CD45, CD11b, CX3CR1, P2RY12, and TMEM119. Immunocytochemistry shortly after plating microglia (shown here with a DAPI stain) reveals prominent expression of TREM2 (green) and IBA1 (red). Function: Human microglia demonstrate phagocytosis and can be stimulated to secrete a variety of cytokines. iPSC derived microglia are immunologically naive. Related diseases: Autism, Epilepsy, Multiple Sclerosis, Alzheimer’s & Huntington’s Disease.

Catalog No. NC2196108


May include imposed supplier surcharges.
Only null left
Add to Cart
This item is not returnable. View return policy

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.